Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Olanzapine (OLA)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 829Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Teva Reveals Promising SOLARIS Results for Olanzapine LAI
    Teva Reveals Promising SOLARIS Results for Olanzapine LAI

    23 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/teva-unveils-promising-solaris-resultsfor-olanzapine-lai-17853

    INDPHARMAPOST
    23 Sep 2025
    Share Share
    Medincell, Teva to Host Investor Call on Phase 3 Olanzapine LAI
    Medincell, Teva to Host Investor Call on Phase 3 Olanzapine LAI

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/medincell-partner-teva-to-host-investor-call-on-completed-phase-3-olanzapine-lai-data-following-psyc

    PHARMAWEB
    17 Sep 2025
    Share Share
    Teva to Release Ph 3 SOLARIS Olanzapine LAI Data Sep 22, 2025
    Teva to Release Ph 3 SOLARIS Olanzapine LAI Data Sep 22, 2025

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3151227/0/en/Teva-to-Host-Conference-Call-to-Discuss-Data-from-the-Completed-Phase-3-SOLARIS-Trial-For-Olanzapine-LAI-TEV-749-on-September-22-2025-After-Presentations-at-the-Psych-Congress-Annu.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    UBI`s Generics Olanzapine Receives Approval in US
    UBI`s Generics Olanzapine Receives Approval in US

    11 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211072

    FDA
    11 Jun 2025
    Share Share
    Teva Shares Uzedy, TEV-‘749 Data In Schizophrenia At ASCO
    Teva Shares Uzedy, TEV-‘749 Data In Schizophrenia At ASCO

    30 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/31/3091373/0/en/Teva-Presents-Latest-Schizophrenia-Portfolio-Data-Including-Real-World-Outcomes-with-UZEDY-risperidone-Showing-Lower-Rates-of-and-Longer-Time-to-Relapse-Compared-to-Oral-Treatment-.html

    GLOBENEWSWIRE
    30 May 2025
    Share Share
    Qilu Pharma`s Generics Olanzapine Receives Approval in US
    Qilu Pharma`s Generics Olanzapine Receives Approval in US

    16 May 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218116

    FDA
    16 May 2025
    Share Share